Since 1949, the AHA has invested more than $4.6 billion in cardiovascular, cerebrovascular, and brain health research.
About AHA Research
Funding research is a cornerstone of the American Heart Association’s lifesaving mission -- a pillar upon which the AHA was founded and a key to our future. The AHA is the largest not-for-profit funding source for cardiovascular and cerebrovascular disease research next to the federal government. New knowledge resulting from AHA funding benefits millions of lives in every corner of the U.S. and around the world:
- Translation into medical advancements
- Updated guidelines for healthcare providers to most effectively treat patients and improve peoples' well-being
- Building careers in science and research
Our bold research vision is guided by 12 Essential Elements to ensure AHA is at the forefront of global changes, emphasizes collaborative and team research, accelerates discovery, and drives groundbreaking research outcomes.
Notice to AHA Research Community Regarding COVID-19
Dear AHA Research Community:
We know many of you are experiencing significant challenges conducting research at your institutions during the coronavirus pandemic. You no doubt have questions about steps the AHA is taking to support your research programs.
First and foremost is the safety of you and your research teams. We anticipate you are following the direction of your sponsoring institutions with regard to access to laboratories and research clinics. We are aware there are varying responses to the pandemic, ranging from all research activities being suspended indefinitely, to reduced operations and remote working until further notice. We understand the need for decisions to be made at the local level, with fluctuating degrees of interruptions on a daily and weekly basis. The AHA has adopted flexible grants management policies in recent years and will expand that flexibility and support as much as possible.
The American Heart Association is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Helpful resources for health systems, clinics, care providers, patients and the public can be found on the COVID-19 Content: An AHA Compendium.
Dr. Mariel Jessup addresses the AHA research community about accommodating awardees who are having difficulties conducting their research due to limitations created by the COVID-19 epidemic.
More than $11 million awarded for Strategically Focused Research Network on Disparities in Cardio-oncology
Teams from the Medical College of Georgia at Augusta University, Boston University School of Medicine, the Medical College of Wisconsin and the University of Pennsylvania comprise the Network.
AHA awardees may apply for a complimentary Precision Medicine Platform workspace to perform data analyses. The workspace will provide up to $50,000 in AWS credits per year during the course of the AHA award. Register for a free account on the AHA Precision Medicine Platform. Learn more about the platform (video).
AHA Awardees Investigate COVID-19 and Its Cardiovascular Impact
The American Heart Association is funding 21 research grants focused on learning more about COVID-19 — 17 are fast-tracked projects and four are special awards to centers of Association’s Health Technologies and Innovation Strategically Focused Research Network. Because of the urgency of this issue, the projects funded are innovative, highly impactful, and anticipated to show progress within 9-12 months.
AHA/CHF Congenital Heart Defect Research Awards
The Children's Heart Foundation and the AHA are jointly funding AHA/CHF Congenital Heart Defect Research Awards. $22.5 million will be awarded for research directly related to congenital heart defects. Learn more: AHA/CHF Congenital Heart Defect Research Awards
Follow us on Twitter @AHA_Research
The official Twitter account for the Research of the American Heart Association